Australia does not need is a tax system that penalises patient saving, prudent risk-taking, and entrepreneurship.

A single cilta-cel infusion after fludarabine/cyclophosphamide produced 100% MRD negativity at 10⁻⁶ by month 2, sustained at ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

Screening guidelines often fail to pinpoint who’s at risk, and few people who are eligible for screening actually get checked ...

Gains in best corrected visual acuity (BCVA) of +9 letters at 36 months among patients with extensive coverage of OpRegen ...

A HEARTBROKEN father has told how his 20-year-old son has been diagnosed with cancer on five separate occasions since the age ...

The costs of healthcare mobility in Sannio remain consistently high, slightly below 20 million euros, involving the use of ...

The 2025 CAQH Index found that more than $20 billion in cost savings could be achieved with more adoption of automatic and ...

Here are the stocks making headlines in midday trading. Rockwell Automation — The manufacturing giant rallied 10% on the back ...

The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be ...

Three years after NordICC trial’s much-debated 10-year results were published, follow-up data showed colonoscopy screening ...

The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed my ...